劉天華（綜述） 許其倓（審校） 上海市東醫院心內科 (上海，200438，中國)
摘要 急性肺栓塞（APE）及時診斷率低，肌鈣蛋白和腦鈉肽在肺栓塞的診斷及危險分層中的作用越來越被人重視。肺栓塞的治療尤其是介入治療近幾年也有較大的進展。本文對急性肺栓塞的臨床預測及治療進展作一綜述，爲其臨床診療提供參考。
關鍵詞 肺栓塞 腦鈉肽 治療 預測
Progress in clinical prediction and treatment of acute pulmanory embolism
LIU Tianhua,XU Qidan.Medical department of cardiology,Shidong hospital, Shanghai city(Shanghai,200438,China)
Abstract The timely diagnosis rate of acute pulmanory embolism(APE) is low, the role of cardiac troponin （cTn）and Brain Natriuretic Peptide(BNP) in the diagnosis and risk stratification is more and more significant.The therapy of acute pulmanory embolism especially in the intervention has made great progress. In this review,we will discuss the progress in clinical prediction and treatment of APE,so as to offer useful refer in the clinical therapy.
Keywords pulmanory embolism; brain natriuretic peptide; therapy; prediction
肺栓塞（PE）是由內源性或外源性栓子堵塞肺動脉引起肺循環障礙所致的一組病理生理綜合征,其發病率、死亡率及臨床誤診率均高.肺栓塞發病率在心血管疾病中僅次于冠心病與高血壓, 是第三位常見的急性心血管病, 病死率僅次于腫瘤和心肌梗死。
